Company: BGLC
Filing Date: 2025-02-28
Form Type: DEFR14A
Source: 0001477932-25-001339
Chunk: 4

Company: BioNexus Gene Lab Corp
Filing Date: 2025-02-28
Form: DEFR14A
Chunk 4
---
 a valid proxy for the Special Meeting. No physical meeting will be held.

This Proxy Statement is being made available to you because you own shares of our outstanding voting stock, including our common stock, no par value (“Common Stock”), as of the Record Date, which entitles you to vote at the Special Meeting. By use of a proxy, you can vote whether or not you attend the Special Meeting. This Proxy Statement describes the matters we would like you to vote on and provides information on those matters.

We have opted to provide our materials pursuant to the “full set delivery option” in connection with the Special Meeting. Under the full set delivery option, a company delivers paper copies of all proxy materials to each stockholder. The Notice of Special Meeting, this Proxy Statement and the form of proxy are first being mailed on or about March 8, 2025, to all stockholders entitled to vote at the Special Meeting. In addition to delivering proxy materials to stockholders, we must also post all proxy materials on a publicly accessible website and provide information to stockholders about how to access that website. Accordingly, you should have received our proxy materials by mail. These materials are available for viewing, printing and downloading on the Internet athttps://onlineproxyvote.com/BGLC/2025 .

Purpose of the Meeting

The purpose of the meeting is to obtain shareholder approval to effect a reverse stock split of the common stock of our Company, in order to maintain the continued listing of our common stock on the Nasdaq Capital Market (See - Page 9). YOUR CONSIDERATION AND VOTE IS VERY IMPORANT. If the Reverse Stock Split Proposal fails, it is likely that the Company will be delisted from the Nasdaq Capital Market. The specific proposals to be considered and acted upon at the Special Meeting are summarized in the Notice of Special Meeting of Stockholders accompanying this Proxy Statement and are described in more detail in this Proxy Statement. We are not aware of any matter to be presented other than those described in this Proxy Statement.

How to Participate in the Special Meeting

The Special Meeting will be a completely virtual meeting of stockholders, which will be conducted exclusively by webcast. You are entitled to participate in the Special Meeting only if you were a stockholder of the Company as of the close of business on the Record Date, or if you hold a valid proxy for the Special Meeting. No physical meeting will be held.

You will be able to participate in the Special Meeting online and submit your questions during the meeting by visiting https